(+)-Matrine

CAS No. 519-02-8

(+)-Matrine( NSC 146051 | NSC 318810 )

Catalog No. M14816 CAS No. 519-02-8

Matrine is an alkaloid found in plants from the Sophora genus. It has a variety of pharmacological effects, including anti-Y effects, and action as a kappa opioid receptor and u-receptor agonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 43 In Stock
25MG 34 In Stock
50MG 49 In Stock
100MG 69 In Stock
200MG 111 In Stock
500MG 245 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (+)-Matrine
  • Note
    Research use only, not for human use.
  • Brief Description
    Matrine is an alkaloid found in plants from the Sophora genus. It has a variety of pharmacological effects, including anti-Y effects, and action as a kappa opioid receptor and u-receptor agonist.
  • Description
    Matrine is an alkaloid found in plants from the Sophora genus. It has a variety of pharmacological effects, including anti-Y effects, and action as a kappa opioid receptor and u-receptor agonist.
  • In Vitro
    Cell Viability Assay Cell Line:A549, SMMC-7721 cells Concentration:0-500 μg/mL for A549 cells, 0-1.5 mg/mL for SMMC-7721 cellsIncubation Time:24-72 h Result:Inhibited the growth of A549 and SMMC-7721 cells.Western Blot AnalysisCell Line:A549, SMMC-7721 cells Concentration:100-250 μg/mL for A549 cells, 0.5-1 mg/mL for SMMC-7721 cellsIncubation Time:24 h Result:Down-regulated the expression of anti-apoptotic protein (Bcl-2) and up-regulated the level of pro-apoptotic protein (bax).ImmunofluorescenceCell Line:HK2 cells Concentration:10 μM Incubation Time:48 h Result:Increased SIRT3 expression reduced under cisplatin stimuli.
  • In Vivo
    Animal Model:Xenograft male C57BL/6mice model (LLC cells)Dosage:40 and 80 mg/kg for 16 consecutive days Administration:Intragastric administration Result:Inhibited tumors growth.Decreased the ratio of CD206+/F4/80+, promoted the expression of CD4+ and CD8+ T cells, and inhibited the expression of Th2 in tumor and spleen tissues. Animal Model:Cisplatin-induced acute kidney injury (AKI) mice model Dosage:5 mg/kg daily for 4 days Administration:Intraperitoneal injections Result:Attenuated tubular injury observed in AKI mice, including renal tubular necrosis,formation of tubular casts, cytoplasmic vacuoles and renal infiltrationof inflammatory cells in mice.Decreased serum levels of TNF-a and IL-6 and the phosphorylation of NF-κB, activated SIRT3/OPA1 axis and improved mitochondrial function.
  • Synonyms
    NSC 146051 | NSC 318810
  • Pathway
    Endocrinology/Hormones
  • Target
    Opioid Receptor
  • Recptor
    κ-opioid receptor
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    519-02-8
  • Formula Weight
    248.37
  • Molecular Formula
    C15H24N2O
  • Purity
    >98% (HPLC)
  • Solubility
    Ethanol: 49 mg/mL (197.29 mM); Water: 11 mg/mL warmed (44.29 mM); DMSO: 49 mg/mL (197.29 mM)
  • SMILES
    O=C1CCC[C@@H]2[C@H]3CCCN4CCC[C@H]([C@@H]34)CN12
  • Chemical Name
    (41S,7aS,13aR,13bR)-dodecahydro-1H,5H,10H-dipyrido[2,1-f:3',2',1'-ij][1,6]naphthyridin-10-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Ren H, et al. Acta Biochim Biophys Sin (Shanghai). 2014 Dec;46(12):1049-55.
molnova catalog
related products
  • (-)-U-50488 hydrochl...

    The more active enantiomer of (±)-U-50488, a potent, selective kappa-opioid receptor agonist with no μ-opioid antagonist effects.

  • BAN ORL 24 dihydroch...

    BAN ORL 24 is a highly potent nociceptin/orphan FQ (N/OFQ) receptor (NOP) antagonist that can be used to study neurological diseases.

  • Calenduloside E

    Calenduloside E exhibits hypoglycemic activities by suppressing the transfer of glucose from the stomach to the small intestine and by inhibiting glucose transport at the brush border of the small intestine in oral glucose-loaded rats.